App-Quantinova.ai

Clinical outcome of acute recoil after everolimus-eluting bioresorbable vascular scaffolds implantation

Otsuki S - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Long coronary lesions treated with thin strut bioresorbable polymer DES: experience from multicentre randomised CENTURY II study

Lesiak M - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Treatment of long lesions with overlapping drug-eluting stents: comparative analysis between second-generation everolimus-eluting stents and first-generation drug-eluting stents

Kozak F - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Six-month clinical outcomes of patients with calcified lesions treated with BVS bioresorbable scaffold

Felix C - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Provisional versus systemic double stenting strategy in coronary bifurcation lesions treated with bioresorbable scaffold

Kawamoto H - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Clopidogrel bisulfate

Everolimus-eluting bioresorbable scaffold as a treatment option for patients with in-stent restenosis: insights from the multicentre GHOST-EU registry

Wiebe J - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: results from a multicentre Italian experience

Moscarella E - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

A novel approach to treat in-stent-restenosis: 6-months results using the Absorb bioresorbable vascular scaffold

Cuculi F - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

Results of 13 years of the DESIRE (Drug-Eluting Stents In the Real-world) registry: the longest available clinical follow-up of a cohort of real-world patients treated exclusively with drug-eluting stents

Costa Jr J.D.R - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Five-year follow-up of safety and efficacy of the Resolute zotarolimus-eluting stent: insights from the RESOLUTE global clinical trial program in approximately 8,000 patients

Silber S - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

ZoMaxx

Three-year results from the multicentre PROMUS Element European post-approval (PE-Prove) registry: outcomes in 1,010 unselected patients treated with a platinum-chromium, everolimus-eluting stent

Moreno R - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Promus Element

Comparative evaluation of high-risk acute coronary syndrome and stable patients treated with bioresorbable polymer DES

Polad J - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Crofelemer

Clinical outcomes of patients with multivessel coronary artery disease after treatment with thin strut DES with bioresorbable polymer: results from CENTURY II trial

Moreno R - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

In-hospital, thirty-day and six-month result of biodegradable polymer coated sirolimus eluting stent in coronary artery lesions (i-TRIAL study)

Polavarapu R.S - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

sirolimus

Bioabsorbable polymer-coated thin strut everolimus-eluting SYNERGY stent for coronary revascularisation in daily clinical practice: one-year results of the SWEET registry (SWiss Evaluation of bioabsorbable polymer-coated Everolimus-eluting coronary sTent)

Puricel S - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

Long-term safety and efficacy of biolimus-eluting coronary stents in an unselected patient population: final 3-year report of the large, multicentre e-BioMatrix registry

Hildick-Smith D - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Umirolimus

Multicentre, prospective, randomised, single blind, consecutive enrolment evaluation of a novolimus-eluting coronary stent system with bioabsorbable polymer compared to a zotarolimus-eluting coronary stent system: long-term (48-month) clinical follow-up from the EXCELLA BD study

Verheye S - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Two-year clinical outcome of patients treated with the Nobori biolimus-eluting stent and XIENCE everolimus-eluting stent for unprotected left main disease

Hiromasa T - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Clinical outcomes in patients with left main disease treated with bioresorbable polymer drug-eluting stent

Vos J - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Biolimus A9

The first establishment of early healing profile and 9-month outcomes of a new polymer-free Biolimus-A9 drug-coated-stent by longitudinal sequential OCT follow-ups: the EGO-BioFreedom study

Lee W.L.S - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Biolimus A9

Filters

7277 Abstracts